96. Crohn disease Clinical trials / Disease details

Clinical trials : 2,442 /  Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT05626023
(ClinicalTrials.gov)		November 30, 202226/10/2022A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's DiseaseA Phase I Study to Evaluate the Safety and Tolerability of Human TH-SC01 Cell Injection for the Treatment of Perianal Fistulas in Crohn's DiseasePerianal Fistula;Crohn's DiseaseDrug: Human TH-SC01 cell injectionJiangsu Topcel-KH Pharmaceutical Co., Ltd.Changhai HospitalNot yet recruiting18 Years70 YearsAll9Phase 1/Phase 2NULL
2NCT04939337
(ClinicalTrials.gov)		November 12, 202010/6/2021A Study of TH-SC01 for Treating Complex Perianal Fistula in Perianal Crohn's Disease.Study to Assess the Safety and Efficacy of Allogeneic Umbilical Cord-derived Mesenchymal Stem Cells(TH-SC01), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.Crohn's DiseaseDrug: TH-SC01Jinling Hospital, ChinaJiangsu Topcel-KH Pharmaceutical Co., LtdEnrolling by invitation18 Years70 YearsAll24Phase 1China